Catheter Precision Inc. (VTAK) - Total Assets
Based on the latest financial reports, Catheter Precision Inc. (VTAK) holds total assets worth $15.86 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore VTAK cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Catheter Precision Inc. - Total Assets Trend (2016–2025)
This chart illustrates how Catheter Precision Inc.'s total assets have evolved over time, based on quarterly financial data. See shareholders equity of Catheter Precision Inc. for net asset value and shareholders' equity analysis.
Catheter Precision Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Catheter Precision Inc.'s total assets of $15.86 Million consist of 2.5% current assets and 97.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.6% |
| Accounts Receivable | $155.00K | 1.0% |
| Inventory | $86.00K | 0.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $15.24 Million | 96.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Catheter Precision Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Catheter Precision Inc..
Key Asset Composition Facts
- Current vs. Non-Current Assets: Catheter Precision Inc.'s current assets represent 2.5% of total assets in 2025, a decrease from 90.9% in 2016.
- Cash Position: Cash and equivalents constituted 0.6% of total assets in 2025, down from 67.1% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 96.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 96.1% of total assets.
Catheter Precision Inc. Competitors by Total Assets
Key competitors of Catheter Precision Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $13.32 Billion |
|
DexCom Inc
NASDAQ:DXCM
|
USA | $6.63 Billion |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Huvitz Co. Ltd
KQ:065510
|
Korea | ₩235.07 Billion |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
Catheter Precision Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.10 | 1.58 | 3.33 |
| Quick Ratio | 0.08 | 1.56 | 2.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.52 Million | $1.21 Million | $13.94 Million |
Catheter Precision Inc. - Advanced Valuation Insights
This section examines the relationship between Catheter Precision Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.36 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -42.9% |
| Total Assets | $15.86 Million |
| Market Capitalization | $2.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Catheter Precision Inc.'s assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Catheter Precision Inc.'s assets decreased by 42.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Catheter Precision Inc. (2016–2025)
The table below shows the annual total assets of Catheter Precision Inc. from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $15.86 Million | -42.89% |
| 2024-12-31 | $27.77 Million | -9.65% |
| 2023-12-31 | $30.74 Million | +82.56% |
| 2022-12-31 | $16.84 Million | -20.00% |
| 2021-12-31 | $21.04 Million | -37.07% |
| 2020-12-31 | $33.44 Million | -24.14% |
| 2019-12-31 | $44.08 Million | -40.46% |
| 2018-12-31 | $74.03 Million | +556.98% |
| 2017-12-31 | $11.27 Million | +92.90% |
| 2016-12-31 | $5.84 Million | -- |
About Catheter Precision Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally … Read more